Colchicine Dosing for Acute Gout Attack
For treating an acute gout flare, use low-dose colchicine: 1.2 mg (two tablets) at the first sign of the flare, followed by 0.6 mg (one tablet) one hour later, for a total of 1.8 mg over one hour—then stop. 1, 2
Dosing Regimen
The American College of Physicians strongly recommends low-dose colchicine when using colchicine to treat acute gout (Grade: strong recommendation, moderate-quality evidence) 1. This recommendation is based on evidence showing that:
- Initial dose: 1.2 mg (two 0.6 mg tablets)
- Second dose: 0.6 mg (one tablet) one hour later
- Total dose: 1.8 mg over one hour
- Maximum dose: Do not exceed 1.8 mg in a one-hour period 2
This low-dose regimen is as effective as the older high-dose regimen (4.8 mg over 6 hours) but with significantly fewer gastrointestinal adverse effects 1. The pivotal trial showed that 38% of patients achieved ≥50% pain reduction at 24 hours with low-dose colchicine versus only 16% with placebo, while the adverse event profile was similar to placebo 3.
Duration of Therapy
Stop after the initial 1.8 mg dose over one hour. This is a single-episode treatment, not a multi-day course 2. The FDA label explicitly states that higher doses have not been found to be more effective 2.
If Already on Prophylactic Colchicine
If the patient is already taking colchicine for gout flare prophylaxis when an acute attack occurs:
- Give the treatment dose (1.2 mg followed by 0.6 mg one hour later)
- Wait 12 hours
- Then resume the prophylactic dose 2
Critical Dosing Adjustments
Drug Interactions
Do not use colchicine with strong CYP3A4 or P-glycoprotein inhibitors (clarithromycin, ketoconazole, ritonavir, etc.)—this is contraindicated due to risk of fatal toxicity 1, 2. If these drugs were used within the prior 14 days, adjust the acute gout treatment dose to:
- 0.6 mg × 1 dose, followed by 0.3 mg one hour later
- Do not repeat for at least 3 days 2
Renal Impairment
Colchicine is contraindicated in patients with renal impairment who are using potent CYP3A4 or P-glycoprotein inhibitors 1. For patients with moderate to severe renal impairment not on these inhibitors, consider dose reduction as plasma levels can exceed therapeutic range by 10-36% 4.
Common Pitfalls to Avoid
Do not use the old high-dose regimen (0.6 mg every hour until relief or toxicity). This causes diarrhea in 77% of patients versus 23% with low-dose, with no additional benefit 3.
Do not repeat the treatment dose within 3 days unless specifically indicated 2. The safety and efficacy of repeat treatment for gout flares has not been established 2.
Start treatment early—colchicine works best when taken at the first sign of a flare ("pills in the pocket" approach) 5.
Do not use colchicine as an analgesic—it is not a pain medication and should not be used to treat pain from other causes 2.
Comparative Effectiveness
While corticosteroids should be considered first-line therapy due to better safety profile and lower cost 1, colchicine remains an effective option when corticosteroids are contraindicated. Low-dose colchicine shows similar efficacy to NSAIDs with comparable adverse event rates 6.
The evidence is high-quality for the effectiveness of low-dose colchicine versus placebo, and moderate-quality for the comparison showing low-dose is as effective as high-dose with fewer adverse effects 1.